Shen Jianfei

State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong, P.R. China.

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers10 papers

Sort

By YearBy Citation

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team

Yalei Zhang,Jianfei Shen,Charles B Simone,Federico Cappuzzo,Kwun M Fong,Rafael Rosell,Joe Y Chang,Luca Ampollini, J Isabelle Choi,Jianxing He,Tao Jiang

Journal of thoracic disease, no. 6 (2018): 3883-3890

WOSBibtex

PUB076 An Analysis of Surveillance, Epidemiology, and End Result Database and a Prognostic Nomogram for Postoperative Small Cell Lung Cancer Patients

Jiaxi He,Jianfei Shen,Jianxing He

Journal of Thoracic Oncology, no. 1 (2017)

Bibtex

An Analysis of Surveillance, Epidemiology, and End Result Database and a Prognostic Nomogram for Postoperative Small Cell Lung Cancer Patients

Jiaxi He,Jianfei Shen

Chest, no. 4 (2016)

Bibtex

GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases

Liping Liu,Chenglin Yang,Jianfei Shen,Liyan Huang,Weixuan Lin,Hailing Tang,Wenhua Liang,Wenlong Shao,Haibo Zhang,Jianxing He

Oncotarget, (2016)

WOSBibtex

Predictive value of BRCA1 expression on the efficacy of chemotherapy based on anti-microtubule agents: a pooled analysis across different malignancies and agents

Qihua He,Mingzhe Zhang, Jianrong Zhang, Shengyi Zhong,Yang Liu,Jianfei Shen,Jiaxi He,Long Jiang,Chenglin Yang, Yuan Zeng, Minzhang Guo, Xuewei Chen

ANNALS OF TRANSLATIONAL MEDICINE, no. 6.0 (2016): 110-110

WOSBibtex

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer

Jin Li,Lin Ye,Xiaoshun Shi,Jingyi Chen,Fenglan Feng, Yaoqi Chen,Yiren Xiao,Jianfei Shen,Peng Li,Wen G Jiang,Jianxing He

Oncotarget, no. 13 (2016): 15678-89

WOSBibtex

The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected

Yijiu Ren, Chenyang Dai,Jianfei Shen,Yang Liu,Dong Xie,Hui Zheng,Jiaxi He,Wenhua Liang,Gening Jiang,Ke Fei,Ping Yang,Jianxing He

Oncotarget, (2016)

WOSBibtex

A bayesian network meta-analysis of different agents or regimens as second-line treatment for SCLC

Qihua He, Jianrong Zhang,Jianfei Shen,Jiaxi He,Wenhua Liang,Jianxing He

Journal of Clinical Oncology, (2016)

Bibtex

The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer

Jin Li,Jie Ting Zhang,Xiaohua Jiang,Xiaoshun Shi,Jianfei Shen,Fenglan Feng,Jingyi Chen,Guihong Liu,Ping He,Juhong Jiang,Lai Ling Tsang,Yan Wang

International journal of oncology, no. 5 (2015): 2107-2115

Cited by7WOSBibtex

Original ResearchLung CancerThe Impact of Visceral Pleural Invasion in Node-Negative Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Long Jiang,Wenhua Liang,Jianfei Shen,Xiaofang Chen,Xiaoshun Shi,Jiaxi He,Chenglin Yang,Jianxing He

Chest, no. 4 (2015): 903-911

Bibtex

View All

Base Info Papers Patents Projects

Shen JianfeiBinding

Papers10 papers

Shen Jianfei